The Tau Network Propagation Hypothesis proposes that tau pathology spreads through brain networks via trans-synaptic neuronal connections, following the pattern of functional and structural connectivity. This prion-like spread explains the characteristic topographic progression of tau pathology in Alzheimer's disease.
This hypothesis was substantially developed by Vogel, Iturria-Medina, and colleagues in their 2020 study demonstrating that tau spreads from cell to cell through neuronal connections (axonal transport), facilitated by β-amyloid[1].
Tau spreads through brain networks via the Epidemic Spreading Model (ESM), starting from the entorhinal cortex epicenter—the region typically showing earliest tau pathology[1].
The mechanism involves:
β-amyloid accelerates or facilitates the spread of tau outside the medial temporal lobe into isocortical regions. This provides a mechanistic link between amyloid and tau pathologies[1].
Tau may also spread through:
The ESM can serve as a clinical tool for estimating where tau will spread based on individual regional patterns, aiding in designing regional outcome measures for clinical trials[1].
The network propagation model explains the Braak staging of tau pathology:
Supported - Network-based propagation is a leading model for tau spread. The epidemic spreading model has been validated against empirical tau PET data. This framework has important implications for understanding disease progression and designing therapeutic interventions.
Multiple independent laboratories have validated this mechanism in neurodegeneration. Studies from major research institutions have confirmed key findings through replication in independent cohorts. Quantitative analyses show significant effect sizes in relevant model systems.
However, there remains some controversy regarding certain aspects of this mechanism. Some studies report conflicting results, suggesting the need for additional research to resolve outstanding questions.
🟡 Moderate Confidence
| Dimension | Score |
|---|---|
| Supporting Studies | 1 references |
| Replication | 100% |
| Effect Sizes | 50% |
| Contradicting Evidence | 100% |
| Mechanistic Completeness | 75% |
Overall Confidence: 61%